Effect of sodium-glucose transport protein 2 inhibitors on all-cause mortality in patients with gout: A multi-center cohort study

被引：0
|
作者：
Chan, Shu-Yen [1 ,2 ,3 ]
Ma, Kevin Sheng-Kai [2 ,4 ,5 ]
机构：
[1] Weiss Mem Hosp, Dept Internal Med, Chicago, IL USA
[2] Univ Penn, Perelman Sch Med, Ctr Global Hlth, Philadelphia, PA USA
[3] Taipei Med Univ, Coll Med, Dept Med, Taipei, Taiwan
[4] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA
[5] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA USA
来源：
METABOLISM-CLINICAL AND EXPERIMENTAL | 2024年 / 153卷
关键词：
SGLT2; inhibitor; gout; all-cause mortality; type 2 diabetes mellitus;
D O I：
10.1016/j.metabol.2024.155887
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0095
引用
收藏
页数：3
相关论文
共 50 条
  • [11] Fasting Glucose and All-Cause Mortality by Age in Diabetes: A Prospective Cohort Study
    Yi, Sang-Wook
    Park, Sangkyu
    Lee, Yong-ho
    Balkau, Beverley
    Yi, Jee-Jeon
    DIABETES CARE, 2018, 41 (03) : 623 - 626
  • [12] INFLATABLE PENILE PROSTHESIS INFECTION IN DIABETIC PATIENTS ON SODIUM-GLUCOSE TRANSPORT PROTEIN 2 INHIBITORS
    Wahlstedt, E.
    Schardein, J.
    Horns, J. J.
    Vichare, V.
    Das, R.
    Hotaling, J.
    Gross, K.
    JOURNAL OF SEXUAL MEDICINE, 2024, 21
  • [13] Cause-specific and all-cause mortality associated with proton pump inhibitors: a cohort study
    Brown, Jeremy P.
    Tazare, John
    Mansfield, Kathryn
    Wing, Kevin
    Root, Adrian
    Tomlinson, Laurie
    Bhaskaran, Krishnan
    Williamson, Elizabeth
    Smeeth, Liam
    Douglas, Ian
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 428 - 428
  • [14] Proton pump inhibitors and risk of all-cause and cause-specific mortality: A cohort study
    Brown, Jeremy P.
    Tazare, John R.
    Williamson, Elizabeth
    Mansfield, Kathryn E.
    Evans, Stephen J.
    Tomlinson, Laurie A.
    Bhaskaran, Krishnan
    Smeeth, Liam
    Wing, Kevin
    Douglas, Ian J.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (08) : 3150 - 3161
  • [15] Assessing the Risk for Gout With Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes A Population-Based Cohort Study
    Fralick, Michael
    Chen, Sarah K.
    Patorno, Elisabetta
    Kim, Seoyoung C.
    ANNALS OF INTERNAL MEDICINE, 2020, 172 (03) : 186 - +
  • [16] INITIATION OF SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS AND RECURRENT GOUT FLARES IN GOUT PATIENTS WITH TYPE 2 DIABETES: A GENERAL POPULATION-BASED COHORT STUDY
    Mccormick, N.
    Yokose, C.
    Wei, J.
    Lu, L.
    Wexler, D.
    Avina-Zubieta, J. A.
    De Vera, M.
    Zhang, Y.
    Choi, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 103 - 104
  • [17] All-cause Mortality and Risk Factors for Death in a Large Multi-center Prospective Registry Cohort of Idiopathic Inflammatory Myositis in China
    Peng, Liying
    Yin, Peng
    Li, Mucong
    Wang, Qian
    Wang, Yanhong
    Zhou, Shuang
    Wu, Chanyuan
    Zhao, Jiuliang
    Xu, Dong
    Li, Mengtao
    Zeng, Xiaofeng
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2289 - 2291
  • [18] Use of sodium-glucose cotransporter-2 inhibitors and the risk for sudden cardiac arrest and for all-cause death in patients with type 2 diabetes mellitus
    Eroglu, Talip E.
    Coronel, Ruben
    Zuurbier, Coert J.
    Blom, Marieke
    de Boer, Anthonius
    Souverein, Patrick C.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2022, 9 (01) : 18 - 25
  • [19] No disparity of the efficacy and all-cause mortality between Asian and non-Asian type 2 diabetes patients with sodium-glucose cotransporter 2 inhibitors treatment: A meta-analysis
    Cai, Xiaoling
    Gao, Xueying
    Yang, Wenjia
    Chen, Yifei
    Zhang, Simin
    Zhou, Lingli
    Han, Xueyao
    Ji, Linong
    JOURNAL OF DIABETES INVESTIGATION, 2018, 9 (04) : 850 - 861
  • [20] Sodium-glucose cotransporter-2 inhibitors and the risk of gout: A Danish population based cohort study and symmetry analysis
    Lund, Lars Christian
    Hojlund, Mikkel
    Henriksen, Daniel Pilsgaard
    Hallas, Jesper
    Kristensen, Kasper Bruun
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 (10) : 1391 - 1395
12345